Related Experiment Videos
[Problems with indications for extracorporeal lithotripsy in urolithiasis].
1Urologická katedra I. lékarské fakulty Univerzity Karlovy a FN2 s FP UNZ NVP, Praha.
Casopis Lekaru Ceskych
|June 15, 1990
Summary
Extracorporeal lithotripsy effectively treats most urolithiasis cases. However, limited resources necessitate careful patient selection and timely treatment to avoid delays and ensure optimal outcomes for kidney stone disease.
Area of Science:
- Urology
- Nephrology
- Medical Technology
Context:
- Urolithiasis, or kidney stone disease, presents a significant clinical challenge.
- Extracorporeal lithotripsy (ECL) is a non-invasive treatment modality for kidney stones.
- A substantial percentage of patients require additional procedures alongside ECL.
Purpose:
- To evaluate the efficacy and applicability of extracorporeal lithotripsy in treating a wide range of urolithiasis cases.
- To assess the impact of treatment capacity and waiting times on patient management and outcomes.
- To advocate for increased accessibility to lithotripsy services.
Summary:
- Extracorporeal lithotripsy has been tested in over 2500 procedures, demonstrating its potential for treating the majority of urolithiasis cases.
- Despite its broad applicability, limited departmental capacity often requires a restricted spectrum of indications.
- Delayed treatment due to long waiting periods can compromise patient health, necessitating alternative approaches or timely intervention.
Impact:
- Optimizing treatment capacity for extracorporeal lithotripsy can improve patient outcomes and reduce healthcare burdens.
- Expanding access to lithotripsy services can ensure timely and effective management of urolithiasis.
- Further integration of lithotriptors in healthcare facilities is crucial for efficient kidney stone treatment.